Ad is loading...
Ad is loading...
ADNRX vs RPTIX
ADNRX vs RPTIX Comparison
Open Charts ADNRX vs RPTIX
American Beacon ARK Transfmt Innov R6
Price$15.04
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
T. Rowe Price Mid-Cap Growth I
Price$112.90
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
ADNRX vs RPTIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
VS
ADNRX vs. RPTIX commentary
Nov 23, 2024
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADNRX is a Sell and RPTIX is a Buy.
FUNDAMENTALS
Fundamentals
RPTIX has more cash in the bank: 31.3B vs. ADNRX (206M). RPTIX pays higher dividends than ADNRX: RPTIX (0.18) vs ADNRX (0.00). ADNRX was incepted earlier than RPTIX: ADNRX (4 years) vs RPTIX (9 years). ADNRX is a more actively managed with annual turnover of: 33.00 vs. RPTIX (21.70). ADNRX has a lower initial minimum investment than RPTIX: ADNRX (0) vs RPTIX (500000). ADNRX annual gain was more profitable for investors over the last year : 24.09 vs. RPTIX (15.16).
| ADNRX | RPTIX | ADNRX / RPTIX | |
| Total Expense Ratio | N/A | N/A | - |
| Annual Report Gross Expense Ratio | N/A | N/A | - |
| Fund Existence | 4 years | 9 years | - |
| Gain YTD | 4.735 | 12.618 | 38% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 500000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 206M | 31.3B | 1% |
| Annual Yield % from dividends | 0.00 | 0.18 | - |
| Returns for 1 year | 24.09 | 15.16 | 159% |
| Returns for 3 years | -62.84 | -13.26 | 474% |
| Returns for 5 years | N/A | 16.85 | - |
| Returns for 10 years | N/A | N/A | - |
View a ticker or compare two or three
VS
VS
Ad is loading...